Notification / Circular No.: S.O. 1582(E) dated March 25, 2026
Applicable Act / Rule: Drugs (Prices Control) Order, 2013
Effective Date: April 01, 2026
The Drugs (Prices Control) Order, 2013 regulates ceiling prices of scheduled formulations to ensure affordability of essential medicines. The National Pharmaceutical Pricing Authority (NPPA) periodically revises these prices based on the Wholesale Price Index (WPI). The last notified ceiling prices were issued vide S.O. 1488(E) dated March 27, 2025. This notification provides the annual WPI-based revision for the year 2025 over 2024.
NPPA has revised the ceiling prices of scheduled formulations based on WPI increase of 0.64956%, applicable from April 01, 2026.
The revised ceiling prices (exclusive of GST) are as follows:
Manufacturers selling above ceiling price shall revise prices downward to comply with the notified ceiling price.
Manufacturers with existing MRP lower than the ceiling price may revise prices based on WPI adjustment as per paragraph 16(2) of DPCO, 2013.
Revised prices must be reported to the Government in Form-II within 15 days of revision.
Manufacturers are required to issue price lists in Form-V and submit to NPPA through IPDMS, with copies to State Drug Controllers and dealers.
Non-compliance shall result in recovery of overcharged amount along with interest under the provisions of DPCO, 2013 read with the Essential Commodities Act, 1955.
Previous price orders corresponding to these formulations stand superseded.
Disclaimer: The information contained in this Article is intended solely for personal non-commercial use of the user who accepts full responsibility of its use. The information in the article is general in nature and should not be considered to be legal, tax, accounting, consulting or any other professional advice. We make no representation or warranty of any kind, express or implied regarding the accuracy, adequacy, reliability or completeness of any information on our page/article.